Sustaining established participant advisory board for the connect for cancer prevention study base task order
Active Awarded Last action
- Contract number
- 75N91022F00001
- Awardee
-
Kaiser Foundation Hospitals UEI P1RTMASB37B5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,345,566
Award facts
- Contract value 91% obligated
-
- $1,345,566.00 Current, with exercised options
- $1,475,544.00 Potential, with all options
- Completion date 91% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R702 Support- Management: Data Collection
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Chicago, IL 60637, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $200,000 | |
| Funding Only Action | $83,276 | |
| Change Order | $0 | |
| Exercise an Option | $140,000 | |
| Funding Only Action | $50,000 | |
| Funding Only Action | $50,000 | |
| Exercise an Option | $200,000 | |
| Exercise an Option | $313,486 | |
| Original award | $308,804 |
About this award
The National Cancer Institute awarded Kaiser Foundation Hospitals a $1.48 million cost-reimbursable delivery order on April 1, 2022, to sustain an established Participant Advisory Board for the Connect for Cancer Prevention Study. This work falls under a parent Indefinite Delivery Contract titled "Cancer Study Cohort Recruitment" and will be performed in Chicago, Illinois, with an ultimate completion date of March 31, 2027. No small business set-aside was applied to this award, reflecting Kaiser Permanente's established capacity to support complex federal research initiatives.
Kaiser Foundation Hospitals, operating through its Kaiser Foundation Research Institute and doing business as Kaiser Permanente, brings substantial research infrastructure and experience to this engagement. As a major non-profit integrated healthcare system with deep federal research credentials, the organization has demonstrated expertise across numerous National Institutes of Health initiatives, including vaccine safety research, epidemiological studies, and population health investigations. The advisory board support under this delivery order aligns with NCI's cohort recruitment and participant engagement priorities, leveraging Kaiser Permanente's access to large patient populations and established research governance structures to sustain participant involvement in this cancer prevention research initiative.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to Kaiser Foundation Hospitals by National Cancer Institute (National Institutes of Health) on April 1, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $1,345,566 on 75N91022F00001. Its potential value, with all options, is $1,475,544.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a delivery order under 75N91018D00021, an indefinite delivery contract, on Cancer Study Cohort Recruitment.
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award